Trials / Withdrawn
WithdrawnNCT02222116
OCT Study of the MGuard Prime Stent in Patients With Heart Attacks
OCT Study of the MGuard Prime Embolic Protection Stent in Patients With Acute ST-segment Elevation Myocardial Infarction
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- InspireMD · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective is to demonstrate that the Flow Area within a blocked coronary vessel as assessed by OCT is greater with the MGuard Prime stent compared to non-mesh control stent (BMS/DES) in subjects undergoing primary PCI for ST-segment elevation MI. The study hypothesis is that end of procedure flow area is greater with the MGuard Prime compared with stenting with a non-mesh DES or BMS.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MGuard Prime | |
| DEVICE | Control BMS DES |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2015-11-01
- Completion
- 2016-01-01
- First posted
- 2014-08-21
- Last updated
- 2015-03-31
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT02222116. Inclusion in this directory is not an endorsement.